Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frank Stephen Hodi, M.D.

Concepts (719)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma1992022525014.750 Why?
Antibodies, Monoclonal98202295495.700 Why?
Skin Neoplasms78202253185.350 Why?
Immunotherapy67202340954.300 Why?
Antineoplastic Combined Chemotherapy Protocols582022112363.440 Why?
Cancer Vaccines2520239972.830 Why?
Antineoplastic Agents632019136262.740 Why?
Neoplasms622023205282.060 Why?
Uveal Neoplasms720203072.020 Why?
Granulocyte-Macrophage Colony-Stimulating Factor1620229031.960 Why?
Mucous Membrane920216641.800 Why?
Proto-Oncogene Proteins B-raf24202119411.760 Why?
Proto-Oncogene Proteins c-kit920177841.760 Why?
Lymphocytes, Tumor-Infiltrating18202010461.560 Why?
Indoles11201918421.280 Why?
Immunomodulation520195291.260 Why?
Tumor Microenvironment18202230541.240 Why?
Oncolytic Viruses320212931.140 Why?
Carcinoma, Non-Small-Cell Lung19202249131.100 Why?
Antigens, CD13202241521.090 Why?
CD8-Positive T-Lymphocytes18202142621.090 Why?
Pneumonia8202120991.080 Why?
Pyrimidines6201729301.040 Why?
Vascular Endothelial Growth Factor A7202034931.040 Why?
Mutation372022292901.030 Why?
Neoplasm Metastasis30202250740.980 Why?
Humans32320237158180.960 Why?
HSP90 Heat-Shock Proteins220184530.930 Why?
T-Lymphocytes, Cytotoxic7201918970.900 Why?
Lung Neoplasms252022125400.890 Why?
Carcinoma, Renal Cell14202029560.890 Why?
Neoplasm Staging452022111450.870 Why?
Aged13220221624680.850 Why?
Middle Aged14620222146660.820 Why?
Brain Neoplasms18202188050.800 Why?
Disease-Free Survival28201970150.790 Why?
Triazoles220189150.770 Why?
Oncolytic Virotherapy420224540.770 Why?
Aged, 80 and over672022583260.750 Why?
Antibodies, Neoplasm420163110.750 Why?
Treatment Outcome702021620400.740 Why?
Protein Kinase C3202012690.740 Why?
Kaplan-Meier Estimate26201967300.730 Why?
X-Linked Inhibitor of Apoptosis Protein12019630.730 Why?
Pyrroles3202011720.730 Why?
Antigens, Differentiation420089640.720 Why?
Drug Resistance, Neoplasm12202151980.700 Why?
Protein Kinase Inhibitors14201954120.680 Why?
CD4-Positive T-Lymphocytes5202043790.670 Why?
Vacuolar Proton-Translocating ATPases220141920.670 Why?
Sarcoidosis, Pulmonary12018470.670 Why?
Granuloma220183300.670 Why?
Male15620223503520.660 Why?
Female16420223772290.660 Why?
Gene Expression Regulation, Neoplastic15202185710.650 Why?
Antibodies, Blocking420192610.640 Why?
Lymphoma5202218810.640 Why?
Antigens, Neoplasm14202119870.630 Why?
Piperazines4201425240.600 Why?
Clinical Trials as Topic21202179600.600 Why?
Colitis7202211360.590 Why?
Angiopoietin-2220161680.590 Why?
Galectin 1120171360.580 Why?
Herpesvirus 1, Human320227250.570 Why?
Molecular Targeted Therapy14202128240.570 Why?
Adult10420222122790.560 Why?
Histone Deacetylase Inhibitors220217900.560 Why?
Epitopes, T-Lymphocyte120198710.540 Why?
Drug Administration Schedule17202150300.540 Why?
GTP-Binding Protein alpha Subunits22012950.530 Why?
Sulfonamides7201419220.530 Why?
Mitogen-Activated Protein Kinase Kinases420216170.530 Why?
Solitary Pulmonary Nodule120182630.520 Why?
Benzamides4201413900.520 Why?
Kidney Neoplasms10202040190.500 Why?
Combined Modality Therapy13202288900.500 Why?
Neovascularization, Pathologic5201926980.500 Why?
Hydroxamic Acids120165000.480 Why?
MAP Kinase Kinase Kinases520192680.480 Why?
Killer Cells, Natural3201821700.470 Why?
Survival Rate222021132130.470 Why?
Clinical Trials, Phase II as Topic820196290.470 Why?
Drug Synergism3201618530.470 Why?
Inhibitor of Apoptosis Proteins420162160.470 Why?
Disease Progression232022132150.470 Why?
HLA Antigens2201815450.470 Why?
Radiotherapy2201916140.450 Why?
T-Lymphocytes142021102840.450 Why?
Prognosis292021290070.440 Why?
Immunity, Humoral520195810.440 Why?
T-Lymphocytes, Regulatory9202030450.430 Why?
Cell Line, Tumor232020167350.430 Why?
Ovarian Neoplasms5202047510.430 Why?
Immunity, Cellular3201616840.420 Why?
Sunlight120133320.420 Why?
Neoplasm Proteins8202137410.410 Why?
Immunophenotyping7202218940.400 Why?
Thyroid Diseases320193840.400 Why?
Dose-Response Relationship, Drug192021112010.400 Why?
Leukocytes, Mononuclear8202217260.390 Why?
Cell Proliferation92021106150.390 Why?
Quinazolines2202014080.390 Why?
Cytokines11202271890.370 Why?
Melanoma, Experimental420195560.360 Why?
Peptide Fragments3201951110.350 Why?
Medical Oncology4202321180.350 Why?
Antibody Formation5201614200.340 Why?
Tumor Burden8202219000.340 Why?
Apoptosis8202199710.340 Why?
Gene Amplification1201310780.340 Why?
T-Lymphocyte Subsets6201918930.340 Why?
Tumor Escape320213370.340 Why?
Maximum Tolerated Dose1020229030.330 Why?
Imidazoles6201912490.320 Why?
Survival Analysis152020105030.320 Why?
Proto-Oncogene Proteins c-met120126040.320 Why?
MAP Kinase Signaling System2201215710.320 Why?
Double-Blind Method112022119450.310 Why?
Diagnostic Imaging2201834940.310 Why?
Autoimmunity3201813280.300 Why?
Hematologic Neoplasms2201616880.300 Why?
Adrenal Cortex Hormones5202118420.290 Why?
Tomography, X-Ray Computed142019203570.290 Why?
Extracellular Signal-Regulated MAP Kinases420136410.290 Why?
Clinical Trials, Phase III as Topic720188140.280 Why?
Oximes420193170.280 Why?
Amino Acid Sequence42021141610.280 Why?
Endocrine System Diseases220182520.280 Why?
Adjuvants, Immunologic320229750.280 Why?
Follow-Up Studies212021393050.280 Why?
Tumor Cells, Cultured9202164820.280 Why?
Immunization, Passive120086300.280 Why?
Rectal Neoplasms2201611210.260 Why?
North America2202112020.260 Why?
Phosphatidylinositol 3-Kinases2202229390.260 Why?
Neoplasm Recurrence, Local10202288960.250 Why?
Insulin-Like Growth Factor I1201220280.250 Why?
Autoantigens120089030.240 Why?
Hematopoietic Stem Cell Transplantation5202251130.240 Why?
Animals4620221694040.240 Why?
Young Adult252021562280.240 Why?
Immunologic Factors3202115710.240 Why?
Hypothyroidism320196490.240 Why?
NF-kappa B1201225530.240 Why?
Immunohistochemistry122019116890.230 Why?
Dose-Response Relationship, Immunologic220213930.230 Why?
Carcinoma, Transitional Cell220227530.230 Why?
Immunosuppressive Agents4202141930.230 Why?
Urologic Neoplasms220183080.220 Why?
Adaptor Proteins, Signal Transducing2201129730.220 Why?
Lymphocytes4202027370.220 Why?
SOXE Transcription Factors12021540.220 Why?
Interferon Regulatory Factor-112021720.220 Why?
Enterocolitis12022930.220 Why?
Thyrotoxicosis22019800.210 Why?
Clinical Trials, Phase I as Topic320183260.210 Why?
Immune Tolerance3201123130.210 Why?
Lymphadenitis120221010.210 Why?
Carcinoma2201623200.210 Why?
Retrospective Studies322022724730.210 Why?
GTP-Binding Protein alpha Subunits, Gq-G11220121330.210 Why?
Hepatitis220202120.210 Why?
Gastritis120221830.210 Why?
Hepatocyte Nuclear Factor 1-alpha120211530.210 Why?
Lymphoma, Large B-Cell, Diffuse2202112930.210 Why?
Cohort Studies182021400320.200 Why?
Histocompatibility Antigens Class I5202113960.200 Why?
Injections, Intralesional120212810.200 Why?
Splenic Neoplasms12021980.200 Why?
Histiocytes120211040.200 Why?
Epitopes4202126490.200 Why?
Monitoring, Immunologic120211060.200 Why?
Primary Myelofibrosis120221970.200 Why?
Pyrimidinones420193730.190 Why?
Recombinant Proteins7201868030.190 Why?
Immunotherapy, Adoptive4202010170.190 Why?